BREAST CANCER METASTATIC

Adverse reaction reported in 13,090 FDA reports across 11 drugs.

13,090
Total Reports
11
Drugs Involved
Letrozole
Most Reported Drug

Drugs Associated with BREAST CANCER METASTATIC

Drugs where "BREAST CANCER METASTATIC" was reported as an adverse event.

# Drug Reports % of Total
1 Letrozole 1,968
15.0%
2 Estrogens, Conjugated 1,683
12.9%
3 Conjugated Estrogens 1,681
12.8%
4 Fulvestrant 1,604
12.3%
5 Ribociclib 1,568
12.0%
6 Conjugated Estrogens / Medroxyprogesterone Acetate 1,506
11.5%
7 Medroxyprogesterone 1,384
10.6%
8 Exemestane 835
6.4%
9 Lapatinib 360
2.8%
10 Goserelin 259
2.0%
11 Alpelisib 242
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused breast cancer metastatic. Always consult your healthcare provider.